Spots Global Cancer Trial Database for Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G)

Official Title: Monocentric Randomized Study Evaluating the Impact of an Early Multidisciplinary Program in Elderly Subjects Starting a Chemotherapy for Digestive Cancer: Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G)

Study ID: NCT05066139

Conditions

Digestive System Disease

Neoplasms

Interventions

EPODIG-G program (coordination of supportive care)

Study Description

Brief Summary: This is a monocentric, comparative, open-label, randomized parallel group study enrolling elderly subjects hospitalized in Strasbourg Europe Cancerology Institute (ICANS), starting chemotherapy or targeted therapy for the treatment of digestive cancer.

Detailed Description: At the ICANS an EPODIG-G program, consisting in a coordination of supportive care that are existing in the Institute, is proposed to elderly patients with digestive cancer. The purpose of this study is to evaluate the impact of this early multidisciplinary geriatric program (EPODIG-G), when it is initiated before therapeutic treatment.